Abstract
Apoliprotein E4 (apoE4) is the strongest genetic risk factor for Alzheimer’s Disease although the detailed method of action is still unclear. Kim et al (JEM 209, 2149) demonstrated that a monoclonal anti-apoE4 antibody reduced the amyloid deposition in an AD mouse model. These data prompted us to investigate human plasma and the intravenous immunoglobulin G (IVIG) preparation Gammagard Liquid (GGL) for the presence of anti-apoE4 IgG.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
